Viewing Study NCT04560751


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-01-25 @ 7:45 AM
Study NCT ID: NCT04560751
Status: UNKNOWN
Last Update Posted: 2020-09-23
First Post: 2020-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TACE Combined With Lenvatinib for Unresectable Hepatocellular Carcinoma (Prolong)
Sponsor: Zhejiang Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Hepatocellular View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Transarterial chemoembolization View
None Lenvatinib View
None Carcinoma, Hepatocellular View